Bioclinica, Inc.

Clario (formerly Bioclinica) is a global clinical trial endpoint technology platform and services provider with 50+ years of expertise supporting drug development. The company delivers comprehensive solutions for efficacy, safety, and patient quality-of-life assessments across decentralized, hybrid, and site-based clinical trials in over 100 countries. Clario's integrated platform combines clinical trial management software, connected medical devices, and AI-powered solutions spanning cardiac safety monitoring, electronic clinical outcomes assessment (eCOA), medical imaging with imaging core lab services, precision motion analysis, and respiratory endpoints. With experience managing 30,000+ trials contributing to 700+ FDA/EMA new drug approvals, Clario employs 3,900+ professionals including 200+ therapeutic area specialists. The platform emphasizes regulatory compliance, patient-centric design, global multilingual deployment, and 24/7 operational support to simplify trial processes for sponsors, contract research organizations (CROs), and research sites.